DFO Management
VC Fund
New York, United States
DFO Management is a VC fund in New York focused on Software and SaaS. MSD Capital was formed to exclusively manage the capital of Michael Dell and his family.
- Total investments:
- 58
- Last investment:
- Lead investor:
- 16%
- Fund size:
- $158M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries DFO Management invests in
Stages DFO Management invests in
Countries DFO Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $3M–$145M
- Series B
- $10M–$130M
Investment Focus
Industry
- Software 12 (21%)
- SaaS 7 (12%)
- Information Technology 7 (12%)
- Internet 6 (10%)
- Financial Services 6 (10%)
Stage
- Funding Round 13 (22%)
- Series B 9 (16%)
- Series A 7 (12%)
- Series C 6 (10%)
- Private Equity 6 (10%)
Country
- United States 44 (76%)
- Canada 1 (2%)
- Finland 1 (2%)
- Switzerland 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Douglas Londal
Partner
|
Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| The Baldwin Group is an independent firm that delivers insurance and risk management insights and solutions.It innovates in the insurance industry by taking a holistic and tailored approach to risk management, insurance, and employee benefits, and by supporting its clients, colleagues, insurance company partners, and communities through thedeployment of vanguard resources and capital to drive their growth. The firm was ranked the # 3 Fastest-Growing Broker by Business Insurance. | Private Equity / Sep 14, 2026 | ||
| Founded in Switzerland in May 2018 out of a passion to turn insights into action in the fight against hypertension, Aktiia’s groundbreaking medical technology provides people and their physicians comprehensive insights into blood pressure patterns that will inform the diagnosis and management of hypertension. Now available in the United Kingdom,Aktiia has received its CE Mark as a Class IIa medical device - signifying that the device has been assessed to meet high safety, health and environmental protection requirements in Europe. To learn more, visit Aktiia.com. | $19M / Series B / Jul 21, 2026 | ||
| Harbor Health is a multi-specialty clinic group that provides smarter health care using technology. The company co-creates a health path that is dedicated to knowing individuals' health goals with the guidance of specialists when needed. Harbor Health was founded in 2022 and is based in Austin, Texas. | $130M / Series B / Sep 09, 2025 | ||
| The Texas Stock Exchange focuses on helping US and global enterprises to have access to US equity capital markets, as well as providing a forum for trading and listing public corporations and the expanding universe of exchange-traded products. | $41M / Private Equity / Feb 03, 2025 | ||
| DeFli Network are one of the global leaders in drone defence systems and combined airspace UTM's. Using IP protected passive radar systems combined with Edge AI, DeFli Networks are the only drone defence system provider that can identify all drones, in all weather and with the longest identification range. DeFli utilizes cryptocurrency toreward hosts of RemoteID sensors as well as offering sponsored devices that earn a fixed percentage of contract revenue. This distributed methodology enables deployment without CapEx and is one of the reasons for the near 2000% increase in sales in 2024. | $7.5M / Series A / Apr 11, 2024 | ||
| Qualtrics is a single system of record for all experience data, managing customer, product, employee, and brand experiences on one platform. | Private Equity / Jun 28, 2023 | ||
| Unlock the extraordinary power of experiences. Elevate the way people interact with your brand. Launch and scale experiential with Way. | $20M / Series A / Nov 01, 2022 | ||
| Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies insidepatient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology. Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck. | $250M / Post-IPO Equity / Oct 12, 2022 | ||
| Opto Investments offers a complete solution for independent investment advisors to access private market investments. | $145M / Series A / Sep 20, 2022 | ||
| Oura develops a smart ring that collects data on various biometrics to support health and wellness. The device tracks sleep, readiness, and activity levels, which users can monitor through the Oura app. It employs sensors to measure heart rate, sleep cycles, and overall activity. The company operates in the health and wellness industry. | Venture - Series Unknown / Apr 05, 2022 | ||
| See all 58 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does DFO Management invest in?
DFO Management invests primarily in Software, SaaS and Information Technology startups, most often at Funding Round and Series B stage. Most of the 58 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does DFO Management invest in?
DFO Management typically joins rounds of $3M–$145M at Series A and $10M–$130M at Series B. These are whole funding-round sizes, not DFO Management's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds DFO Management took part in.
How do I contact DFO Management?
Public channels for DFO Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at DFO Management?
The team at DFO Management includes Douglas Londal (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
